Cargando…
Curcumin analog GO‐Y030 boosts the efficacy of anti‐PD‐1 cancer immunotherapy
Regulatory T cells (Tregs) in the tumor microenvironment regulate tumor immunity. Programmed cell death protein 1 (PD‐1) is known to be expressed on Tregs and plays crucial roles in suppressing tumor immunity. However, the immune checkpoint inhibitor, anti‐PD‐1 antibody, is known to promote the prol...
Autores principales: | MaruYama, Takashi, Kobayashi, Shuhei, Shibata, Hiroyuki, Chen, WanJun, Owada, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645716/ https://www.ncbi.nlm.nih.gov/pubmed/34529884 http://dx.doi.org/10.1111/cas.15136 |
Ejemplares similares
-
The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells
por: MaruYama, Takashi, et al.
Publicado: (2021) -
Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose
por: MaruYama, Takashi, et al.
Publicado: (2023) -
Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
por: Lin, L, et al.
Publicado: (2011) -
Structure-Activity Relationships of the Antitumor C(5)-Curcuminoid GO-Y030
por: Kohyama, Aki, et al.
Publicado: (2015) -
The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice
por: Shimizu, Kana, et al.
Publicado: (2020)